Biotec Pharmacon ASA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biotec Pharmacon ASA with three other
pharmaceutical manufacturers in Europe:
sales of 38.76 million Norwegian Kroner [US$4.61 million]
(6.81 million Euro [US$7.29 million]
of which 63%
was OUTLINCENCEDPRODUCTS), and
based in France
(6.17 million Euro [US$6.60 million]
of which 100%
was Research & Development).
During the year ended December of 2015, sales at
Biotec Pharmacon ASA were NOK 53.28 million (US$6.33 million).
increase of 61.3%
versus 2014, when the company's sales were NOK 33.03 million.
This was the third consecutive year of growth at Biotec Pharmacon ASA.
Sales of Betaglucans saw an increase
77.3% in 2015, from
NOK 16.77 million to NOK 29.73 million.